Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unicentric Castleman Disease”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableStudy completedNCT05440305
What this trial is testing

Unicentric Form of Castleman Disease - Surgery Therapy Benefit

Who this might be right for
Castleman DiseaseUnicentric Castleman DiseaseSurgery
Charles University, Czech Republic 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06643091
What this trial is testing

Nintedanib Treatment in Unicentric Castleman Disease

Who this might be right for
Castleman Disease
Assistance Publique - Hôpitaux de Paris 13
Testing effectiveness (Phase 2)Study completedNCT00132015
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Institutes of Health Clinical Center (CC) 37
Not applicableLooking for participantsNCT05663502
What this trial is testing

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Who this might be right for
Anal CarcinomaHematopoietic and Lymphoid Cell NeoplasmHIV Infection+9 more
AIDS Malignancy Consortium 200
Not applicableLooking for participantsNCT05081141
What this trial is testing

HHV8 and Solid Organ Transplantation

Who this might be right for
HHV8HHV8 InfectionHHV8-Related Malignant Neoplasm+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 250
Early research (Phase 1)Active Not RecruitingNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 155
Early research (Phase 1)Study completedNCT01183598
What this trial is testing

Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment

Who this might be right for
Castleman's Disease
Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Ended earlyNCT04838860
What this trial is testing

Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease

Who this might be right for
Idiopathic Multicentric Castleman's Disease
RECORDATI GROUP 22
Testing effectiveness (Phase 2)Looking for participantsNCT05907759
What this trial is testing

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Who this might be right for
Lymphoma, Primary Effusion
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT07085039
What this trial is testing

Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman's Disease (CD)Idiopathic Multicentric Castleman's Disease
University of Pennsylvania 14
Testing effectiveness (Phase 2)Looking for participantsNCT06052618
What this trial is testing

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

Who this might be right for
KSHV Inflammatory Cytokine Syndrome (KICS)Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
National Cancer Institute (NCI) 75
Not applicableLooking for participantsNCT05283993
What this trial is testing

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+9 more
Peking University First Hospital 2,000
Testing effectiveness (Phase 2)Ended earlyNCT00127569
What this trial is testing

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

Who this might be right for
HIV InfectionsGiant Lymph Node Hyperplasia
French National Agency for Research on AIDS and Viral Hepatitis 25
Early research (Phase 1)Active Not RecruitingNCT02659930
What this trial is testing

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 62
Post-approval studies (Phase 4)WithdrawnNCT00361933
What this trial is testing

Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

Who this might be right for
Giant Lymph Node Hyperplasia
University of Washington
Testing effectiveness (Phase 2)Active Not RecruitingNCT04585893
What this trial is testing

Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi

Who this might be right for
Multicentric Castleman Disease
UNC Lineberger Comprehensive Cancer Center 15
Not applicableStudy completedNCT00695422
What this trial is testing

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

Who this might be right for
Aids-related MalignanciesLymphomaPrecancerous Condition+1 more
AIDS Malignancy Consortium 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT03933904
What this trial is testing

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's Disease, Multicentric
University of Pennsylvania 7
Early research (Phase 1)Ended earlyNCT03864419
What this trial is testing

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Who this might be right for
Burkitt LymphomaKSHV-associated Multicentric Castleman DiseaseDiffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)WithdrawnNCT02228512
What this trial is testing

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Who this might be right for
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman DiseasePrimary Effusion Lymphoma
National Cancer Institute (NCI)
Load More Results